Avalon GloboCare Overview
- Founded
-
2014
- Status
-
Public
- Employees
-
6
- Stock Symbol
-
AVCO
- Investments
-
6
- Share Price
-
$0.59
- (As of Tuesday Closing)
Avalon GloboCare General Information
Description
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high impact, transformative biotechnology, clinical applications, and healthcare facility management. It has two reportable segments: real property operating segment which is the key revenue driver; medical-related consulting services segment. The company focuses on the diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
NAS
Primary Office
- 4400 Route 9 South
- Suite 3100
- Freehold, NJ 07728
- United States
+1 (732) 000-0000
Avalon GloboCare Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.59 | $0.59 | $0.40 - $1.15 | $58.4M | 89.8M | 132K | -$0.10 |
Avalon GloboCare Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 45,129 | 76,500 | 93,221 | 144,242 |
| Revenue | 1,409 | 1,391 | 1,378 | 1,546 |
| EBITDA | (7,741) | (8,451) | (12,132) | (17,481) |
| Net Income | (8,457) | (9,090) | (12,679) | (18,070) |
| Total Assets | 10,275 | 10,242 | 10,366 | 10,491 |
| Total Debt | 3,007 | 3,298 | 3,733 | 3,190 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Avalon GloboCare Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Avalon GloboCare Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and emp
Biotechnology
Freehold, NJ
6
As of 2021
00.000
000000000
00.000
000000
od tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercit
0000 000000000
Miramar, FL
00
As of 0000
000000000 -
000000
giat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deser
0000 000000000
Cambridge, MA
000
As of 0000
00000
00000000
00000
Add Comparison
Avalon GloboCare Competitors (10)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kimera Labs | Corporation | Miramar, FL | 00 | 000000000 - | ||
| 000000 | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 00000000 | 00000 |
| 00000 000000000000 | Venture Capital-Backed | Woburn, MA | 0 | 00.00 | 0000000000 0 | 00.00 |
| 0000000 | Private Equity-Backed | Prague, Czech Republic | 0000 | 00000 | 000000&0 | |
| 000000000 | Corporation | Melbourne, Australia | 00 | 00000 | 000000000 | 00000 |
Avalon GloboCare Patents
Avalon GloboCare Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220031836-A1 | Emulsomes comprising s-layer fusion proteins and methods of use thereof | Pending | 03-Aug-2020 | 000000000 | |
| US-20210403509-A1 | S-layer vaccine fusion proteins and methods of use | Pending | 24-Jun-2020 | 000000000 |
Avalon GloboCare Executive Team (6)
Avalon GloboCare Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 000 00.0 | Avalon GloboCare | Chief Executive Officer & Board Member | 000 0000 |
| 0000 00 | Avalon GloboCare | Chief Operating Officer, Operations & Board Member | 000 0000 |
| 000000 0000000 00 | Self | Board Member | 000 0000 |
| 0000000 000000 | Avalon GloboCare | Board Member | 000 0000 |
| 0000000 0000000 000 | Self | Board Member | 000 0000 |
Avalon GloboCare Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Avalon GloboCare Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Avalon GloboCare Investments & Acquisitions (6)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 0000000 | 14-Jun-2021 | 0000000000 | Drug Discovery | 00000 000 | |
| 00000000 0000 | 23-Oct-2018 | 00000 0000 | Drug Discovery | 00000 000 | |
| 000000 000000 | 01-Sep-2018 | 00000 0000 | Biotechnology | 00000 000 | |
| 0000000 00000 | 25-Oct-2017 | 0000000000 | 00000 | Drug Discovery | 00000 000 |
| Genexosome Technologies | 25-Oct-2017 | Merger/Acquisition | 00.00 | Application Software | 00000 000 |